Concepedia

Publication | Open Access

A phase 1 study of efatutazone, an oral peroxisome proliferator‐activated receptor gamma agonist, administered to patients with advanced malignancies

DOIFull Paper Access

65

Citations

29

References

2012

Year

Michael J. Pishvaian, John L. Marshall, Andrew J. Wagner, Jimmy Hwang, Shakun Malik, Ion Cotarla, John F. Deeken, Aiwu Ruth He, Hirut Daniel, Abdel‐Baset Halim,
Cancer

Abstract

Efatutazone demonstrates acceptable tolerability with evidence of disease control in patients with advanced malignancies.

References

YearCitations

Page 1